Keywords analizadas
Utility
Treated
Tolerability
Tasigna
Summary
Site
Saglio
Response
Representative
Phase
Patients
Novartis
Nilotinib
Myeloid
Milestones
Mg
Leukemia
Intended
Information
Imatinib
Hughes
Healthcare
Frontline
Efficacy
Early
Dosing
Cml
Chronic
Capsules
Administration